Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.

McAdoo, SP; Tanna, A; Hrušková, Z; Holm, L; Weiner, M; Arulkumaran, N; Kang, A; Satrapová, V; Levy, J; Ohlsson, S; Tesar, V; Segelmark, M; Pusey, CD

doi:https://www.dx.doi.org/10.1016/j.kint.2017.03.014

Dear Spiral user, We’re pleased to introduce Helix, https://helix.imperial.ac.uk/ Imperial’s new repository for research datasets. Please use Helix for all future dataset deposits. There is no change to Spiral - continue depositing as usual. For queries, contact the Research Data Management team at rdm-enquiries@imperial.ac.uk. Kind regards, the Spiral Team. The Spiral team

Request a copy of the file

Enter the following information to request a copy for the following item: Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.

Requesting the following file: 1-s2.0-S0085253817302077-main.pdf

Back